newsfilter
← Latest News
PR Newswire·

LogicBio® Therapeutics to Present at H.C. Wainwright Global Investment Conference

LEXINGTON, Mass., May 17, 2022 /PRNewswire/ -- LogicBio Therapeutics, Inc. (NASDAQ:LOGC), a clinical-stage genetic medicine company, today announced that president and chief executive officer, Frederic Chereau, will present a company overview at the H.